| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |